Estrogen Receptors: How Do They Signal and What Are Their Targets | Physiological Reviews
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor α Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase | PLOS ONE
Estrogen signaling: An emanating therapeutic target for breast cancer treatment - ScienceDirect
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
EREs).
New insights into acquired endocrine resistance of breast cancer
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
Fulvestrant (ICI 182,780)-dependent Interacting Proteins Mediate Immobilization and Degradation of Estrogen Receptor-α* - Journal of Biological Chemistry
Crossroads of Estrogen Receptor and NF-κB Signaling | Science's STKE
Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways in: Journal of Molecular Endocrinology Volume 41 Issue 5 (2008)
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Dual-mechanism estrogen receptor inhibitors | PNAS
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Dual-mechanism estrogen receptor inhibitors | PNAS
New insights into acquired endocrine resistance of breast cancer
